Daliri Sara, Bekker Charlotte L, Buurman Bianca M, Scholte Op Reimer Wilma J M, van den Bemt Bart J F, Karapinar-Çarkit Fatma
Faculty of Health, ACHIEVE Center of Expertise, Amsterdam University of Applied Sciences, Amsterdam, 1105 BD, the Netherlands.
Department of Clinical Pharmacy, OLVG hospital, Amsterdam, 1061AE, The Netherlands.
BMC Health Serv Res. 2019 Mar 29;19(1):204. doi: 10.1186/s12913-019-4028-y.
During transitions from hospital to home, up to half of all patients experience medication-related problems, such as adverse drug events. To reduce these problems, knowledge of patient experiences with medication use during this transition is needed. This study aims to identify the perspectives of patients on barriers and facilitators with medication use, during the transition from hospital to home.
A qualitative study was conducted in 2017 among patients discharged from two hospitals using a semi-structured interview guide. Patients were asked to identify all barriers they experienced with medication use during transitions from hospital to home, and facilitators needed to overcome those barriers. Data were analyzed following thematic content analysis and visualized using an "Ishikawa" diagram.
In total, three focus groups were conducted with 19 patients (mean age: 70.8 (SD 9.3) years, 63% female). Three barriers were identified; lack of personalized care in the care continuum, insufficient information transfer (e.g. regarding changes in pharmacotherapy), and problems in care organization (e.g. medication substitution). Facilitators to overcome these barriers included a personal medication-counselor in the care continuum to guide patients with medication use and overcome communication barriers, and post-discharge follow-up care (e.g. home visits from healthcare providers).
During transitions from hospital to home patients experience individual-, healthcare provider- and organization level barriers. Future research should focus on personal-medication counselors in the care continuum and post-discharge follow-up care as it may overcome communication, emotional, information and organization barriers with medication use.
在从医院过渡到家庭的过程中,多达一半的患者会经历与药物相关的问题,如药物不良事件。为了减少这些问题,需要了解患者在这一过渡期间用药的经历。本研究旨在确定患者在从医院过渡到家庭期间对用药障碍和促进因素的看法。
2017年,对两家医院出院的患者进行了一项定性研究,采用半结构化访谈指南。要求患者识别他们在从医院过渡到家庭期间用药所经历的所有障碍,以及克服这些障碍所需的促进因素。采用主题内容分析法对数据进行分析,并使用“石川”图进行可视化展示。
总共对19名患者(平均年龄:70.8(标准差9.3)岁,63%为女性)进行了三个焦点小组访谈。确定了三个障碍:护理连续过程中缺乏个性化护理、信息传递不足(如关于药物治疗变化的信息)以及护理组织方面的问题(如药物替代)。克服这些障碍的促进因素包括护理连续过程中有个人用药顾问来指导患者用药并克服沟通障碍,以及出院后随访护理(如医护人员家访)。
在从医院过渡到家庭的过程中,患者会经历个人、医护人员和组织层面的障碍。未来的研究应关注护理连续过程中的个人用药顾问和出院后随访护理,因为这可能克服用药过程中的沟通、情感、信息和组织障碍。